Renal Function in Patients with Essential Hypertension Receiving Nadolol

Overview

Journal Br Med J

Specialty General Medicine

Date 1980 Aug 9

PMID 6107151

Citations 6

Authors

C H Hobson

Affiliations

Soon will be listed here.

Citing Articles

A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia.

Kalsoom S, Rasool M, Imran I, Saeed H, Ahmad T, Alqahtani F Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399480 PMC: 10891759. DOI: 10.3390/ph17020265.

Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.

OCallaghan W, Laher M, McGarry K, OBrien E, OMalley K Br J Clin Pharmacol. 1983; 16(4):417-21.

PMID: 6138058 PMC: 1428043. DOI: 10.1111/j.1365-2125.1983.tb02187.x.

Beta-blockers and renal function.

Wilkinson R Drugs. 1982; 23(3):195-206.

PMID: 6122552 DOI: 10.2165/00003495-198223030-00002.

Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.

Pun K, Yeung C, Chan M Br J Clin Pharmacol. 1985; 20(4):401-4.

PMID: 3907676 PMC: 1400880. DOI: 10.1111/j.1365-2125.1985.tb05084.x.

Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Mackay I, MacNICOL A, Smith H, Cumming A, Watson M Br J Clin Pharmacol. 1985; 20(3):197-203.

PMID: 2864052 PMC: 1400691. DOI: 10.1111/j.1365-2125.1985.tb05061.x.

References

Ibsen H . Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci. 1973; 44(2):129-34. DOI: 10.1042/cs0440129. View

Warren D, Swainson C, Wright N . Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension. Br Med J. 1974; 2(5912):193-4. PMC: 1610826. DOI: 10.1136/bmj.2.5912.193. View